Esmaeil Shabaninezhad

Chemical Injures Research Center, Systems Biology and Poisonings Institutes, Baqiyatallah University of Medical Sciences, Tehran, Iran

Publications

• Research Article   
  The Therapeutic Efficacy of Interferon Alpha-2b in Patients with Primary and Recurrent Pterygium
  Author(s): Seyed-Hashem Daryabari*, Mohammadhosein Ranjkesh, Mohammadreza Saeedifar, Hamidreza Torabi, Esmaeil Shabaninezhad and Alireza Shabaninezhad
  
  Background: Pterygium is a growing fibrovascular tissue from the bulbar conjunctiva and can affect the cornea. Pterygium prevalence varies from 10.2% globally in a meta- analysis study, and in Iran, 13.34% was reported. Apart from those that should be surgically removed, there is currently no definitive treatment to eliminate and prevent pterygium growth, and only symptomatic treatment is used (lubrication). On the other hand, research has shown the antiangiogenic and antifibrotic properties of IFN alpha-2b (interferon alfa-2b). The goal of this research was to see how effective IFN alpha-2b is, in treating primary and recurrent pterygium in order to improve quality of life and reduce burden. Materials and Methods: This study was performed on 34 eyes of 34 consecutive patients suffering from primary and recurrent pte.. Read More»
  

  Abstract HTML PDF